Published in JAMA on September 10, 1997
Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol (1998) 2.82
Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2003) 2.71
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (2006) 2.69
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One (2009) 2.51
Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis (2009) 2.25
Severity prediction rules in community acquired pneumonia: a validation study. Thorax (2000) 2.14
Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob Agents Chemother (2003) 1.33
Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors. Int J Tuberc Lung Dis (2009) 1.31
Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol (2001) 1.31
Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3. Chem Res Toxicol (2006) 1.21
Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women. Am J Public Health (2000) 1.16
Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population. West J Med (1998) 1.14
Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. Biochem J (2005) 1.09
Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J (2012) 1.03
Drug-resistant tuberculosis. CMAJ (2000) 1.01
The tuberculosis epidemic. Scientific challenges and opportunities. Public Health Rep (1998) 1.01
Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region. PLoS One (2013) 0.98
Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med (2001) 0.97
3'-Phosphoadenosine-5'-phosphosulfate reductase in complex with thioredoxin: a structural snapshot in the catalytic cycle. Biochemistry (2007) 0.96
Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies. Lung India (2012) 0.94
Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994. Public Health Rep (1999) 0.93
Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. Clin Infect Dis (2012) 0.91
Improved program activities are associated with decreasing tuberculosis incidence in the United States. Public Health Rep (2006) 0.87
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob Agents Chemother (2002) 0.85
Prevalence and risk factors of drug-resistant tuberculosis along the Mexico-Texas border. Am J Public Health (2000) 0.84
Defending the public's health against tuberculosis. JAMA (1997) 0.83
What it takes to control tuberculosis. Am J Public Health (1998) 0.82
Tuberculosis control: challenges of an ancient and ongoing epidemic. Public Health Rep (2007) 0.81
Tuberculosis among foreign-born children in the state of Florida, 1993-1999: a re-emergence phase after a sustained decline? Wien Klin Wochenschr (2003) 0.81
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe. Int J Tuberc Lung Dis (2016) 0.77
Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist (2017) 0.75
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11
An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med (1998) 6.60
Nationwide survey of drug-resistant tuberculosis in the United States. JAMA (1994) 6.14
The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med (1995) 5.34
Racial/ethnic differences in the risk of AIDS in the United States. Am J Public Health (1988) 4.89
Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA (1994) 4.44
Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med (1996) 4.27
HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med (1993) 3.78
Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis (1997) 3.18
Prevalence of HIV infection among intravenous drug users in the United States. JAMA (1989) 3.13
Brief report: congenital tuberculosis. N Engl J Med (1994) 2.95
Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med (1998) 2.92
Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med (1999) 2.66
The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep (1990) 2.64
Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med (1992) 2.63
Birthplace and the risk of AIDS among Hispanics in the United States. Am J Public Health (1989) 2.60
Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA (1997) 2.54
Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA (1991) 2.51
Occupational risk of the acquired immunodeficiency syndrome among health care workers. N Engl J Med (1986) 2.51
Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. Am J Public Health (1995) 2.34
Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA (2000) 2.31
Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J (1987) 2.13
Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis (1999) 2.05
Preventing multidrug-resistant tuberculosis. JAMA (1996) 2.03
Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis (1997) 2.02
HIV seroprevalence surveys in sexually transmitted disease clinics. Public Health Rep (1990) 2.02
Completeness of tuberculosis case reporting, San Juan and Caguas Regions, Puerto Rico, 1992. Public Health Rep (1996) 1.93
Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.90
The incidence of AIDS among blacks and Hispanics. J Natl Med Assoc (1987) 1.89
Supplementing tuberculosis surveillance with automated data from health maintenance organizations. Emerg Infect Dis (2000) 1.86
Completeness and timeliness of tuberculosis case reporting. A multistate study. Am J Prev Med (2001) 1.77
Overseas screening for tuberculosis in immigrants and refugees to the United States: current status. Clin Infect Dis (1996) 1.74
HIV infection among homeless adults and runaway youth, United States, 1989-1992. Field Services Branch. AIDS (1994) 1.71
A train passenger with pulmonary tuberculosis: evidence of limited transmission during travel. Clin Infect Dis (1999) 1.67
Transmission of Mycobacterium tuberculosis from medical waste. JAMA (2000) 1.67
Completion of tuberculosis therapy for patients reported in the United States in 1993. Int J Tuberc Lung Dis (1999) 1.66
Transmission of HIV-associated tuberculosis to health-care workers. Lancet (1992) 1.61
HIV seroprevalence surveys in drug treatment centers. Public Health Rep (1990) 1.59
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med (1992) 1.56
Epidemiology of cytomegaloviral infections: recommendations for prevention and control. Rev Infect Dis (1985) 1.51
'Normal' CSF in bacterial meningitis. JAMA (1980) 1.46
The association between occupation and tuberculosis. A population-based survey. Am J Respir Crit Care Med (1996) 1.46
Modelling tuberculosis trends in the USA. Epidemiol Infect (2012) 1.42
Tuberculosis surveillance in the United States: case definitions used by state health departments. Am J Public Health (1996) 1.39
Mycobacterium tuberculosis transmission in healthcare settings: is it influenced by coinfection with human immunodeficiency virus? Infect Control Hosp Epidemiol (1993) 1.38
Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis (2000) 1.36
AIDS trends among Hispanics in the United States. Am J Public Health (1993) 1.35
The need for epidemic intelligence. Public Health Rep (1996) 1.35
Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin. Clin Infect Dis (1997) 1.29
Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. Arch Intern Med (2000) 1.28
Current poliomyelitis immunization policy in the United States. Pediatr Ann (1990) 1.28
Risk factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med (1998) 1.27
Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis (2003) 1.26
HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control. Am J Public Health (1992) 1.23
Epidemiology of tuberculosis among children in the United States: 1985 to 1994. Pediatr Infect Dis J (1996) 1.23
Estimating HIV levels and trends among patients of tuberculosis clinics. Public Health Rep (1990) 1.19
Epidemiology of HIV-1 infection in bisexual women. J Acquir Immune Defic Syndr (1992) 1.18
Determining HIV seroprevalence among women in women's health clinics. Public Health Rep (1990) 1.18
Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis (1992) 1.18
The global threat of drug-resistant tuberculosis. N Engl J Med (1998) 1.17
Sentinel surveillance of human immunodeficiency virus infection in women seeking reproductive health services in the United States, 1988-1989. The Field Services Branch. Obstet Gynecol (1992) 1.16
Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recomm Rep (1990) 1.16
The fall after the rise: Tuberculosis in the United States, 1991 through 1994. Am J Public Health (1998) 1.15
Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis (1992) 1.13
Transmission of Mycobacterium tuberculosis associated with air travel. JAMA (1994) 1.12
Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol (1986) 1.12
Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. Am J Epidemiol (1996) 1.09
The good news and the bad news about multidrug-resistant tuberculosis. Clin Infect Dis (1995) 1.09
Teenagers at risk of human immunodeficiency virus type 1 infection. Results from seroprevalence surveys in the United States. Arch Pediatr Adolesc Med (1995) 1.08
National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome. Arch Intern Med (1995) 1.08
Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services. Int J Tuberc Lung Dis (1999) 1.08
The epidemiology of tuberculosis in the United States. Clin Chest Med (1997) 1.08
The changing face of tuberculosis. Annu Rev Med (1995) 1.07
Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak. Clin Infect Dis (2002) 1.06
Youth at risk. Sex, drugs, and human immunodeficiency virus. Am J Dis Child (1992) 1.06
Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infect Control Hosp Epidemiol (2001) 1.05
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Boosting of tuberculin sensitivity among Southeast Asian refugees. Am J Respir Crit Care Med (1994) 1.01
Heterosexual transmission of hepatitis B virus in Belle Glade, Florida. Belle Glade Study Group. J Infect Dis (1990) 1.00
Acute hemorrhagic conjunctivitis Investigation of a large-scale community outbreak in Dade County, Florida. JAMA (1983) 0.98
Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. Clin Infect Dis (1993) 0.98
Risk factors for positive mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics (2001) 0.98
Distribution of AIDS cases, by racial/ethnic group and exposure category, United States, June 1, 1981-July 4, 1988. MMWR CDC Surveill Summ (1988) 0.98
Tuberculosis in children younger than five years old: New York City. Pediatr Infect Dis J (1995) 0.96